Download d vi sol8/27/2023 ![]() A61P19/08- Drugs for skeletal disorders for bone diseases, e.g.A61P19/00- Drugs for skeletal disorders.A61P- SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS.A61K9/0056- Mouth soluble or dispersible forms Suckable, eatable, chewable coherent forms Forms rapidly disintegrating in the mouth Lozenges Lollipops Bite capsules Baked products Baits or other oral forms for animals.A61K9/0053- Mouth and digestive tract, i.e.A61K9/0012- Galenical forms characterised by the site of application.A61K9/00- Medicinal preparations characterised by special physical form.castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin A61K47/44- Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42 Natural or modified natural oils, fats or waxes, e.g.fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters A61K47/14- Esters of carboxylic acids, e.g.ethers, acetals, ketones, quinones, aldehydes, peroxides natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite carriers or inert additives Targeting or modifying agents chemically bound to the active ingredient A61K47/00- Medicinal preparations characterised by the non-active ingredients used, e.g.A61K45/06- Mixtures of active ingredients without chemical characterisation, e.g. ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |